Navigation Links
InspireMD to Participate in Benchmark Company, LLC 2011 One-On-One Investor Conference
Date:5/6/2011

TEL AVIV, Israel, May 6, 2011 /PRNewswire/ -- InspireMD, Inc. (OTC BB: NSPR) ("Inspire" or the "Company"), the developer of the MGuard™ mesh protective stent system, today announced that Mr. Ofir Paz, InspireMD's co-founder and chief executive officer, and Mr. Craig Shore, chief financial officer, will participate in the Benchmark Company, LLC One-on-One Investor Conference on Thursday, May 12, 2011 at The Pfister Hotel, 424 East Wisconsin Ave., Milwaukee, Wis. The conference will include a number of one-on-one meetings arranged by Benchmark with investors. Investors planning to attend the conference should contact their Benchmark representative to arrange a meeting.

Management will discuss its proprietary stent platform technology: MGuard™, featuring a patent-pending micron mesh technology that wraps a stent, reducing Major Adverse Cardiac Events [MACE] by filtering debris and minimizing vessel injury by distributing strut pressure. MGuard™ has been implanted in thousands of patients with encouraging clinical results in Europe and Latin America. MGuard™ is a solution for high-risk Acute Coronary Syndrome (heart attack) patients — a market of over two million patients per year. The presentations will also discuss the Company's ongoing clinical efforts, including a randomized trial in Europe, Latin America and South Africa, chaired by Dr. Gregg Stone, to support its regulatory approval efforts, and its focus on securing FDA approval to sell its products in the U.S., including its collaboration with the Harvard Clinical Research Institute (HCRI), an international leader in design and conduct of coronary device trials, for U.S. FDA trials.

About The Benchmark Company, LLC

Headquartered in New York City, The Benchmark Company, LLC is an institutional brokerage firm with a strong sales/trading presence in addition to its rapidly expanding research and investment banking arms. In just nine years, Benchmark has e
'/>"/>

SOURCE InspireMD, Inc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. InspireMD to Commence Trading as a Public Company Under Ticker Symbol "NSPR"
2. InspireMD Boosts MGuard Production Capacity
3. InspireMD Becomes a Supporting Organization in the Growing Stent for Life Initiative
4. For the First Time, at EuroPCR, InspireMD Will Provide a Sneak Preview of the Next Generation MGuard Prime(R), a State of the Art Net Protective Cobalt Chromium Stent System
5. InspireMD Announces the Enrollment of the 1st Patient in the MGuard iMOS Registry, the Registry Will Enroll 1000 Patients
6. Hill-Rom to Participate in the Bank of America Merrill Lynch Health Care Conference
7. ViroPharma to Participate In Three May Healthcare Investor Conferences
8. Hill-Rom to Participate in the Deutsche Bank 36th Annual Health Care Conference
9. Hologic, Hospira, Boston Scientific, Allergan to Participate in Leading Medical Device Manufacturing Symposium
10. Sinovac Participates in UBS Greater China Healthcare Corporate Day
11. Three States Sign on to Participate in NABPs Interconnected Prescription Monitoring System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... PARK, Kan. , July 24, 2014 /PRNewswire/ ... of two compounds that will be added to ... with Australian-based CIMTECH Pty Ltd, a biotechnology company. ... PAR 122 have shown promise in bone regeneration ... license to develop the compounds for the veterinary ...
(Date:7/24/2014)... MARSEILLE , Frankreich, July ... , Weltweite Exklusivlizenz der Universität ... Entwicklung von Tests auf SF3B1-Mutationen, einschließlich von ... Neuer Test weist Mutationen des SF3B1-Gens nach, ... einen günstigen Krankheitsverlauf vermuten lassen  ...
(Date:7/24/2014)... Calif., July 24, 2014  Abaxis, Inc. (NasdaqGS: ... blood analysis systems, today reported financial results for the ... First quarter overview: , Revenues of $47.5 million, ... Diluted EPS of $0.21, up 50% over last year,s ... market revenues of $7.2 million, up 20% over last ...
Breaking Medicine Technology:Parnell Acquires License for Intellectual Property and Rights to Develop Compounds for Bone and Dermal Regeneration 2Parnell Acquires License for Intellectual Property and Rights to Develop Compounds for Bone and Dermal Regeneration 3Parnell Acquires License for Intellectual Property and Rights to Develop Compounds for Bone and Dermal Regeneration 4QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 2QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 3QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 4QIAGEN erweitert Pipeline für die personalisierte Medizin um vielversprechende genomische Biomarker zur Prognosebestimmung bei Blutkrebsbehandlungen 5Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 2Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 3Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 4Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 5Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 6Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 7Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 8Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 9Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 10Abaxis Reports Financial Performance for the First Quarter of Fiscal 2015 11
... (Nasdaq: ERES ), a global provider of ... device industries, today announced that Michael McKelvey will be ... Officer and a director of ERT.  The Company,s Board ...  Dr. McKelvey will continue in his current position until ...
... Sept. 10 Covance Inc. (NYSE: CVD ) ... Global Healthcare Conference on Tuesday, September 14, 2010 at 2:10 ... presentation at www.covance.com .  In order to register and ... Covance, with headquarters in Princeton, New Jersey, is ...
Cached Medicine Technology:ERT Announces Upcoming Retirement of Michael McKelvey as Chief Executive Officer 2ERT Announces Upcoming Retirement of Michael McKelvey as Chief Executive Officer 3
(Date:7/25/2014)... Progress in understanding the molecular genetics of brain ... brain tumor treatments, according to Patrick Wen, MD, professor ... for Neuro-Oncology, Dana-Farber Cancer Institute. , At the American ... in Chicago, July 25-26, Dr. Wen will moderate a ... the development of new treatments and advancing strategies to ...
(Date:7/25/2014)... San Jose, CA (PRWEB) July 25, 2014 ... MaaS360 WorkPlace Partner Program . Splashtop Business and ... MaaS360 Market, and will leverage the MaaS360 WorkPlace ... corporate data. , Splashtop Business and Splashtop Enterprise offer ... using any device. High performance, ease of ...
(Date:7/25/2014)... July 25, 2014 Garth Brooks Chicago ... the Allstate Arena in Rosemont. Garth Brooks was one of ... released his first single in 1989. Since "Much Too Young (To ... the shows from the Tulsa, Okl. native and in the years ... see him back on a stage and in the recording studio. ...
(Date:7/25/2014)... be treated more quickly after Manchester research , ... blood test on arrival, is effective in reducing ... study shows., The findings of a research group ... could potentially make a huge difference to a ... most common reason for emergency hospital admission. In ...
(Date:7/25/2014)... (PRWEB) July 25, 2014 Ross A. ... has been invited to join the exclusive Obagi Clinical ... leading facial plastic surgeons, plastic surgeons and dermatologists. ... this exclusive Advisory Board of thought leaders held its ... the meeting was to give Obagi the opportunity to ...
Breaking Medicine News(10 mins):Health News:Immunotherapy, Targeted Molecular Therapies Among Promising New Treatments for Brain Tumors 2Health News:Immunotherapy, Targeted Molecular Therapies Among Promising New Treatments for Brain Tumors 3Health News:Immunotherapy, Targeted Molecular Therapies Among Promising New Treatments for Brain Tumors 4Health News:Splashtop Joins the MaaS360 WorkPlace Partner Program 2Health News:Splashtop Joins the MaaS360 WorkPlace Partner Program 3Health News:Splashtop Joins the MaaS360 WorkPlace Partner Program 4Health News:Garth Brooks Chicago Tickets for Performance at Allstate Arena in Rosemont Go On Sale July 25th 2Health News:Garth Brooks Chicago Tickets for Performance at Allstate Arena in Rosemont Go On Sale July 25th 3Health News:Heart attack patients could be treated more quickly after Manchester research 2Health News:Renowned Melbourne Plastic Surgeon to Join Private Medical Advisory Board 2
... $1.1 million grant to a team of scientists at the ... technology for studying the link between human health and disease ... body. The grant is one of 14 awarded nationwide ... the Human Microbiome Project. The human microbiome consists of beneficial ...
... HealthDay Reporter , TUESDAY, Sept. 14 (HealthDay News) -- ... accurate decisions in all aspects of life, new findings suggest. ... the journal Current Biology theorize that action games ... drawn from their senses in decision-making, a skill known as ...
... , TUESDAY, Sept. 14 (HealthDay News) -- Nearly half ... payments from companies that make orthopedic devices such as artificial ... articles on such devices in medical journals, a new study ... who read the articles aren,t aware of conflicts of interest ...
... Researchers at Children,s Hospital Boston have developed a ... North Carolina at Chapel Hill to engage health care ... safety and real-time pharmacovigilance. The application, "MedWatcher," allows users ... official alerts from the Food and Drug Administration (FDA), ...
... today (14 September 2010), shows that the watercress compound is ... plays a critical role in cancer development. As tumours ... send out signals which make surrounding normal tissues grow new ... nutrients. The research, led by Professor Graham Packham ...
... ROCKVILLE, Maryland, September 14, 2010 Neuralstem, Inc. ... stem cells survived in rat brains affected by ... animals showed significant improvement in some motor skill ... of Adherent Human Neural Stem Cells To Reverse ...
Cached Medicine News:Health News:New research technology to target human gut bacteria 2Health News:Action-Packed Video Games May Be Good for You After All 2Health News:Action-Packed Video Games May Be Good for You After All 3Health News:Medical Study Authors Often Fail to Disclose Industry Ties 2Health News:New iPhone app, 'MedWatcher,' to support real-time drug safety surveillance 2Health News:Watercress may 'turn off' breast cancer signal 2Health News:Neuralstem stem cells survive and differentiate into neurons in rats with stroke 2
... SureStep™ Drug Screen Tests are available in ... MDMA (Ecstasy). Designed using Microgenics Antibody Technology, ... only point of care immunoassay targeted to ... both MDA and MDEA but no cross-reactivity ...
AccuSign® DOA Series Opiates Test...
... The SureStep™ Drug Screen Tests are available ... for MDMA (Ecstasy). Designed using Microgenics Antibody ... the only point of care immunoassay targeted ... for both MDA and MDEA but no ...
The SEDITAINER Erythrocyte Sedimentation Rate (ESR) System is for collection of blood specimens for the measurement of ESR within the blood collection tube, using the SEDITAINER ESR Stand....
Medicine Products: